AbbVievsLifeStance Health

ABBV and LFST stock compared: price, dividend, valuation and results, from SEC filings.

LFST

LifeStance Health Group, Inc.

$14.08

Value $5.5B

-0.49%
LFST's page

AbbVie (ABBV) has a market value of $522B and LifeStance Health (LFST) $5.5B. Over the last year, with dividends, ABBV moved +30.3% and LFST +118.6%. The P/E is 50.7 for ABBV and 76.3 for LFST. Dividend yield: ABBV 2.35%, LFST none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABBV$522B

    LFST$5.5B

    ABBV is 95 times LFST

  • Revenue, 12 months

    ABBV$66.0B

    LFST$1.7B

    ABBV is 39 times LFST

  • Net income, 12 months

    ABBV$10.3B

    LFST$72M

    ABBV is 144 times LFST

  • Operating margin

    ABBV32.2%

    LFST6.2%

    26.0 points apart

  • ROIC

    ABBV25.7%

    LFST4.7%

    21.0 points apart

  • P/E

    ABBV50.7

    LFST76.3

    LFST is 1.5 times ABBV

  • Dividend yield

    ABBV2.4%

    LFST0.0%

    2.4 points apart

  • 5-year return

    ABBV+201.5%

    LFST+36.2%

    165.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABBV+201.5%

LFST+36.2%

10020030020222023202420252026
Returns by period
PeriodABBVWith dividendsLFSTWith dividends
1 year since November 12, 2025+30.3%Price +26.5%+118.6%Price +118.6%
3 years since November 13, 2023+135.3%+33.0% a yearPrice +112.8%+149.2%+35.6% a yearPrice +149.2%
5 years since November 12, 2021+201.5%+24.7% a yearPrice +152.2%+36.2%+6.4% a yearPrice +36.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABBVAbbVieLFSTLifeStance Health

Valuation

ABBVLFST
Valuation
Price$295.03$14.08
Market value$522B$5.5B
Enterprise value (EV)$592B$5.5B
P/E50.776.3
P/E, 5-year median57.0–
P/B–3.7
EV/EBIT27.953.2
Free cash flow yield3.6%3.3%

Results and growth

ABBVLFST
Results and growth
Revenue, 12 months$66.0B$1.7B
Net income, 12 months$10.3B$72M
Free cash flow, 12 months$18.9B$179M
Earnings per share, 12 months$5.81$0.18
Revenue growth, year on year8.6%13.9%
Revenue growth a year, past+5.9%over 5 years+20.9%over 4 years
EPS growth a year, past-2.8%over 5 years–

Margins and returns on capital

ABBVLFST
Margins and returns on capital
Gross margin73.7%–
Operating margin32.2%6.2%
Net margin15.7%4.3%
ROIC25.7%4.7%
ROE–4.8%

Balance sheet

ABBVLFST
Balance sheet
Cash$10.8B$219M
Total debt$80.9B$476M
Net debt / EBITDA3.20.4
Interest cover7.1×10.6×

Dividends and buybacks

ABBVLFST
Dividends and buybacks
Dividend yield2.4%–
Dividend per share, 12 months$6.92–
Dividend growth a year, past+6.6%over 5 years–
Buyback yield0.2%–
Shareholder yield2.5%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABBV or LFST

Didn't find what you were looking for?

Ask us
Which is bigger, AbbVie or LifeStance Health?

By market value, AbbVie ($522B) is about 95.1 times LifeStance Health ($5.5B), at today's prices.

How did ABBV and LFST stock do over the last 5 years?

Since November 12, 2021, ABBV's price moved +152.2% and LFST's +36.2%. With dividends: ABBV +201.5% (+24.7% a year), LFST +36.2% (+6.4% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABBV or LFST?

The dividend yield at today's price is 2.35% for AbbVie and none for LifeStance Health. Over the last twelve months they paid $6.92 and – per share.

What is the P/E of ABBV and LFST?

At today's price, the P/E is 50.7 for ABBV and 76.3 for LFST. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, AbbVie or LifeStance Health?

Over the last twelve months, the net margin was 15.7% for AbbVie and 4.3% for LifeStance Health, and the operating margin 32.2% and 6.2%. Revenue was $66.0B and $1.7B.

Which is the better investment, AbbVie or LifeStance Health?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.